| 64.72 Delayed Data As of 4:00pm ET |  -2.42 / -3.60%Today’s Change | 40.91 Today|||52-Week Range 86.58 | +19.72% Year-to-Date |
| Approval of a Game-Changing Gene Therapy for SMA Delivers a Win for Novartis and Rege... 7:50pm / MotleyFool.comFOO - Paid Partner Content | Ionis Pharmaceuticals Is 40% of the Way There May 14 / MotleyFool.com - Paid Partner Content |
| Previous close | 67.14 |
| Today’s open | 67.63 |
| Day’s range | 63.80 - 68.74 |
| Volume | 2,588,017 |
| Average volume (3 months) | 1,194,969 |
| Market cap | $9.5B |
| Earnings growth (last year) | +2,515.50% |
| Earnings growth (this year) | -112.85% |
| Earnings growth (next 5 years) | +28.00% |
| Revenue growth (last year) | +18.12% |
| P/E ratio | 24.0 |
| Price/Sales | 12.09 |
| Price/Book | 8.87 |
| Today’s change | Today’s % change | |
|---|---|---|
| SAGESAGE Therapeutics In... | +0.12 | +0.07% |
| MYLMylan NV | -0.19 | -0.99% |
| SRPTSarepta Therapeutics... | +2.59 | +2.19% |
| BHCValeant Pharmaceutic... | -0.15 | -0.63% |
| Next reporting date | August 5, 2019 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $599.7M |
| Annual profit (last year) | $276.9M |
| Net profit margin | 46.17% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Stanley T. Crooke |
Chief Operating Officer & Director Brett P. Monia |
Corporate headquarters Carlsbad, California |
